California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo authorization by the FDA for its AI tool for prostate cancer ...

Please provide your email address to receive an email when new articles are posted on . Researchers at The Ohio State University have harnessed artificial intelligence machine learning processes to ...

This is an intelligent monitoring tool designed to support clinicians in keeping a close, ongoing watch over patients after ...